Synthesis and serotonergic activity of 2-oxadiazolyl-5-substitutedWjW-dimethyltryptamines: Novel antagonists for the vascular 5-HT1B-like receptor

Journal of the Chemical Society - Perkin Transactions 1

Volumn , Issue 19, 1999, Pages 2725-2733

  Moloney, Gérard P ^a   Martin, Graeme R ^a   Mathews, Ncil ^b   MacLennan, Steve ^b   Dodsworth, Susan ^a   Sang, Pang Yih ^a   Knight, Cameron ^a   Maxwell, Miles ^b   Glen, Robert C ^b  

^a MONASH UNIVERSITY   (Australia)

^b ROCHE BIOSCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0003869118     PISSN: 0300922X     EISSN: None     Source Type: Journal    
DOI: 10.1039/a903325d     Document Type: Article

References (40)

1. C. Gluchowski, T.A. Branchek, R. L. Weinshank and P. R. Hartig, Anmi. Rep. Med. Chem., 1993, 28,29.
2. P.R. Hartig, N, Adham, J. Zgombic, R. L. Weinshank and T. A. Branchek, Drug. Dev. Res., 1992,26,215.
3. G.R. Martin and P. P. A. Humphrey, Neuropharmacology, 1994,33, 261.
4. D. Hoyer, D.E. Clark and J. R. Fozard, PhannacoL Re\:, 1994,46, 157.
5. E. Zifa and G. Filiion, Pharmacol. Re\\, 1992,44,401.
6. 5-HT|D Receptor: a progress review, Nciirochem. Res., 1990, 15, 573.
7. P.R. Hartig, D. Hoyer, P. P. A. Humphrey and G. R. Martin, Trends. Pharmacol. Sci., 1996, 17, 103.
8. P.P. A. Humphrey, W. Feniuk, M. J. Perren, H. E. Connor,'A. W. Oxford, I. H. Coates and D. Butina, Br. J. Pharmacol., 1988, 94, 1123.
9. K.L. Dechant and S. P. Clissold, Drugs, 1992,43,776.
10. P.C. North, Migraine Therapy-Serotonin to Sumatriptan in Medicinal Chemistry: Principles and Practice, ed. F. G. King, The Royal Society of Chemistry, 1994.
11. R.C. Glen, A. P. Hill, G. R. Martin and A. D. Robertson, Headache, 1994,34,307.
12. R.C. Glen, G. R. Martin, A. P. Hill, R. M. Hyde, P. M. Woolard, J. A. Salmon, J. Buckingham and A. D. Robertson, J. Med. Client., 1995,38, 3566.
13. L.J. Street, R. Baker, J. L. Castro, M. S. Chambers, A. R. Guiblin, S. C. Hobbs, V. G. Matassa, A. J. Reeve, M. S. Beer, D. N. Middlemiss, A. J. Noble, J. A. Stanton, K. Scholey and R. J. Hargreaves, J Med. Chen,., 1993,36, 1529.
14. P. Schoeffter and D. Hoyer, Naunyn-Sclmiedebergs Arch. Pharmacol., 1989,340, 135.
15. S.J. Peroutka and B. G. McCarthy, Eur. J. Pharmacol, 1989, 163, 133.
16. E. Hamel, Current Drugs: Serotonin ID Research Alert, 1996,1, 19.
17. G.R. Martin, Serotonin Receptor Involvement in the Pathogenesis and Treatment of Migraine, in Blue Books on Neurology, eds. S. Silberstein and P. J. Goad-4by, Butterworth-Heinemann, 1997.
18. E.P. McFadden, J. G. Clarke, G. J. Davies, J. C. Kaski, A. W and M. A. Maseri, New Engl. J. Med., 1991,324, 648.
19. P. Golino, F. Piscione, J.T. Willerson, M. Cappelli-Bigazzi, A. Focaccio, B. Villari, C. Indolfi, E. Russolillo, M. Condorelli, M. Chiariello, New Engl. J. Med., 1991,324,641.
20. A. Maseri, Circulation, 1990,11-13.
21. D.J. Fitzgerald, L. Roy, F. Catella and G. A. Fitzgerald, New Engl. JAM, 1986,315,983.
22. P.B. Bradley, G. Engel, W. Feniuk, J. R. Fozard, P. P. A. Humphrey, D. N. Middlemiss, E. J. Mylecharane, B. P. Richardson and P. R. Saxena, Nciirophannacology, 1986, 25, 563.
23. A.L. Scherbel and J. N. Harrison, Angiology, 1959,10,29.
24. G.P. Moloney, A. D. Robertson, G. R. Martin, S. MacLennan, N. Mathews, S. Dodsworth, Pang Yih Sang, C. Knight and R. C. Glen, J Med. Chem., 1997,40,2347.
25. J. Saunders, M. Cassidy, S.B. Freedman, E. A. Harley, I. L. Iverson, C. Kneen, A. MacLeod, K.. J. Merchant, R. J. Snow and R. Baker, J.Med. Chem., 1990,33, 1128.
26. C.J. Swain, R. Baker, C. Kneen, J. Moseley, J. Saunders, E. M. Seward, G. Stevenson, M. Beer, J. Stanton and K. Watling, J. Med. Chem., 1991,34, 140.
27. L.J. Street, R. Baker, J. L. Castro, M. S. Chambers, A. R. Guiblin, S. C. Hobbs, V. G. Matassa, A. J. Reeve, M. S. Beer, D. N. Middlemiss, A. J. Noble, J. A. Stanton, K. Scholey and R. J. Hargreaves,./ Med. Chem., 1993,36, 1529.
28. B.S. Orlek, F. E. Blaney, F. Brown, M. S. Clark, M. S. Hadley, J. Hatcher, G. J. Riley, H. E. Rosenberg, H. J. Wadsworth and P. Wyman, J. Med. Chem., 1991,34, 2726.
29. G.P. Moloney, G. R. Martin, N. Mathews, A. Milne, H. Hobbs, S. Dodsworth, Pang Yih Sang, C. Knight, M. Williams, M. Maxwell and R, C. Glen, J. Med. Chem., 1998, submitted.
30. G.P. Moloney, G. R. Martin, N. Mathews, H. Hobbs, S. Dodsworth, Pang Yih Sang, C. Knight, M. Williams, M. Maxwell and R. C. Glen, J. Chem. Soc., Perkin Trans. I, 1999, 2699.
31. (a) E. Nordmann, Chem. Ber., 1884, 17, 2746;
32. (b) R. Lenaers, C. Moussebois and F. Eloy, Heir. Chim. Ada, 1962,45,441.
33. B.E. Cantrell, Eli Lilly and Company, European Patent EP 0 506 478 A 1,1992.
34. R.C. Glen, G. R. Martin, A. P. Hill, R. M. Hyde, P. M. Woolard, J. A. Salmon, J. Buckingham and A. D. Robertson, J. Med. Chem., 1995,38, 3566; P. Woolard and J. A. Salmon, unpublished results.
35. G.P. Moloney, G. R. Martin, N. Mathews, H. Hobbs, S. Dodsworth, Pang Yih Sang, C. Knight, M. Maxwell and R. C. Glen, under preparation.
36. G.R. Martin and S. J. MacLennan, Naiinyii-Schiniedebergs Arch. Pharmacol., 1990, 342, 111.
37. S.J. MacLennan and G. R. Martin, Br. J. Pliarin., 1992,107,418.
38. P. LelT and G.R. Martin, 'Differences in agonist dissociation constant estimates for 5-HT and 5-HTa receptors: a problem of acute desensitization?', Br. J. Pharmacol., 1998,95, 569.
39. P. Woolard and J.A. Salmon, unpublished results.
40. Sybyl 6.1 molecular modelling package, Tripos Associates, St Louis MO 63144, U.S.A., 1992.